+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

  • ID: 4142710
  • Report
  • April 2020
  • Region: Russia
  • 133 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher, an industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.

The Russian pharmaceutical market was worth $29.6B in 2012, but declined to $22.7B by 2016 due to the devaluation of the Russian ruble during the Russian Financial Crisis (2014-2017). By 2018, the economy had recovered and the pharmaceutical market had grown to $26.8B. It is forecast to reach $38.5B by 2025 at a Compound Annual Growth Rate (CAGR) of 5.3%. The Russian pharmaceutical market faces stiff competition from generic drugs. In 2018, generic drugs accounted for 61.8% of sales of the retail commercial market, while original drugs accounted for 38.2%. In 2015, the medical devices market in Russia was worth $7.07B, which increased to $7.92B in 2019. It is expected to grow at a CAGR of 4.1% from 2019 to reach $10.07B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Novartis, Pfizer, GlaxoSmithKline, and Pharmstandard.
  • Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Roche, Essilor, and Zimmer Biomet
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Russian healthcare market
Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Russia’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Russia’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Note: Product cover images may vary from those shown
Table of Contents
1.1 List of Figures
1.2 List of Tables

2 Executive Summary
2.1 Executive Summary
2.2 Key Highlights
2.3 Key Events: Russian Pharmaceutical News, 2014-2020
2.4 Key Events: Russian Pharmaceutical Market
2.5 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.6 Key Events: Mergers and Acquisitions
2.7 Country Profile, Russia, 2019

3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Pharma 2020
3.3 Pharmaceutical Market - Exports
3.4 Pharmaceutical Market - Imports
3.5 Pharmaceutical Supply Channels, Russia
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Russia
3.7 COVID-19 Epidemiology, Russia
3.8 COVID-19 Impact and Developments in Healthcare Market, Russia
3.9 Pharmaceutical Market - Major Players

4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Segments
4.3 Medical Device Market - Major Players

5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers

6 Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Russia 2019-2020
6.2 Deal Analysis: Medical Devices, Russia 2019-2020

7 HealthTech Landscape
7.1 HealthTech Landscape
7.2 Digital Health Companies, Russia
7.3 Key HealthTech Deals, Russia
7.4 Telemedicine Regulations, Russia
7.5 HealthTech Landscape- Russia- Benefits and Risks

8 Market Access
8.1 Overview of Healthcare System, Russia
8.2 Reimbursement Process, Russia
8.3 Overview of Health Insurance, Russia
8.4 Healthcare Spending and Health Price Index, Russia
8.5 Pricing Policies, Russia
8.6 Regulatory Landscape, Russia
8.6.1 Market Authorization for Pharmaceutical Drugs, Russia
8.6.2 Regulatory Reforms, Russia
8.6.3 Market Authorization for Medical Devices, Russia
8.6.4 Licensing Process for Pharmaceutical Exports and Imports
8.6.5 Intellectual Property Rights, Patent, Russia
8.6.5 Clinical Trial Regulations, Russia
8.6.6 Pharmaceutical Clinical Trials Landscape, Russia
8.6.7 Pharmaceutical Advertising Regulations, Russia
8.6.8 Labeling Regulations, Russia

9 Country Healthcare Landscape
9.1 Healthcare Initiatives
9.2 Healthcare Facilities, Russia
9.3 Healthcare Parameters, Russia
9.4 Life Expectancy and Immunization Rate, Russia
9.5 Environmental Health, Russia
9.6 Healthcare Personnel, Russia
9.7 Disease Burden, Russia
9.8 Healthcare Expenditure

10 Trade Associations, Russia

11 Trade Fairs, Russia

12 Opportunities and Challenges

13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.1.4 Expert Panel
13.2 Bibliography
13.3 Contact
13.4 Disclaimer

List of Tables
Table 1: Major Pharmaceutical Distributors, Russia, 2018
Table 2: Sales Structure of RTU drugs by ATC groups, Russia, 2018
Table 3: COVID-19 Indicators (Number of cases), Global and Russia, 2020
Table 4: COVID-19 Clinical Trials, Russia, 2020
Table 5: COVID-19 Test Kits, Russia, 2020
Table 6: Orthopedic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 7: Ophthalmic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 8: Diagnostic Imaging Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 9: Cardiovascular Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 10: In Vitro Diagnostics Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 11: Out-Patient Drug Reimbursement Eligibility, Russia, 2019
Table 12: Medical Equipment Risk Classification, Russia, 2019
Table 13: Patent Fees, Russia, 2019
Table 14: Trade Fairs, 2020

List of Figures
Figure 1: Pharmaceutical Market, Russia, Revenue ($B), 2012-2018
Figure 2: Medical Device Market, Russia, Revenue ($B), 2015-2020
Figure 3: Country Profile, Russia, 2019
Figure 4: Pharmaceutical Market, Russia, Revenue (RUB B and $B), 2012-2018
Figure 5: Pharmaceutical Market, Russia, Revenue Forecast (RUB B and $B), 2019-2025
Figure 6: Pharma 2020, Russia, 2020
Figure 7: Pharmaceutical Exports ($M), Russia, 2010-2019
Figure 8: Top Export Partners, Russia, 2019
Figure 9: Pharmaceutical Imports ($B), Russia, 2010-2019
Figure 10: Top Import Partners, Russia, 2019
Figure 11: OTC Market, Russia, Major Category (%), 2019
Figure 12: OTC Market, Russia, Revenue ($M), 2013-2020
Figure 13: COVID-19 (Number of cases), Russia, 2020
Figure 14: COVID-19 (Number of deaths), Russia, 2020
Figure 15: Pharmaceutical Market, Major Players, 2018
Figure 16: Medical Device Market, Russia, Revenue ($B), 2015-2020
Figure 17: Medical Device Market, Russia, Revenue Forecast ($B), 2021-2025
Figure 18: Medical Devices Market, Major Segments (%), Russia, 2019
Figure 19: Orthopedic Devices Market, Russia, Revenue ($M), 2015-2022
Figure 20: Orthopedic Devices Market, Russia, Market Share of Major Players (%), 2019
Figure 21: Ophthalmic Devices Market, Russia, Revenue ($M), 2015-2022
Figure 22: Ophthalmic Devices Market, Russia, Market Share of Major Players (%), 2015
Figure 23: Diagnostic Imaging Market, Russia, Revenue ($M), 2015-2022
Figure 24: Diagnostic Imaging Market, Russia, Market Share of Major Players (%), 2015
Figure 25: Cardiovascular Devices Market, Russia, Revenue ($M), 2015-2022
Figure 26: Cardiovascular Devices Market, Russia, Market Share of Major Players (%), 2018
Figure 27: In Vitro Diagnostics Market, Russia, Revenue ($M), 2015-2022
Figure 28: In Vitro Diagnostics Market, Russia, Market Share of Major Players (%), 2015
Figure 29: Diagnostic Market, Russia, Revenue ($M), 2015-2020
Figure 30: Diagnostic Market, Russia, Revenue ($M), 2021-2025
Figure 31: Medical Device Market, Russia, Revenue ($B) of Major Companies, 2017
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Russia, 2019-2020
Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Russia, 2019-2020
Figure 34: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Russia, 2019-2020
Figure 35: Top Therapy Areas by Deal Value, Pharmaceutical Market, Russia, 2019-2020
Figure 36: Top Therapy Areas by Deal Number, Pharmaceutical Market, Russia, 2019-2020
Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Russia, 2019-2020 (by value and by number)
Figure 38: Deal Value and Deal Count, Medical Devices, Russia, 2019-2020
Figure 39: Deal Value and Deal Count Quarterly, Medical Devices, Russia, 2019-2020
Figure 40: Overview of Healthcare System, Russia, 2019
Figure 41: Public Provision of Pharmaceuticals, Russia, 2019
Figure 42: Government Health Insurance (% of population), Russia, 2010-2018
Figure 43: Out-of-Pocket Expenditure ($ per capita), Russia, 2010-2017
Figure 44: Health Price Index (% change), Russia, 2011-2019
Figure 45: Drug price regulation, Russia, 2019
Figure 46: Filing Procedure for Registration of Maximum Selling Price for EDL Drugs, Russia, 2019
Figure 47: Roszdravnadzor, Organization Chart, 2020
Figure 48: Rospotrebnadzor, Organization Chart, 2020
Figure 49: Drug Approval Process, Russia, 2019
Figure 50: Drug Approval Overall Process, Russia, 2019
Figure 51: Rospatent Organization Structure, Russia, 2019
Figure 52: Patent Application Process, Russia, 2019
Figure 53: Pharmaceutical Clinical Trials Count By Trial Status, Russia, 2018-2019
Figure 54: Pharmaceutical Clinical Trials Count By Phase, Russia, 2018-2019
Figure 55: Pharmaceutical Clinical Trials Count By Therapy Area, Russia, 2018-2019
Note: Product cover images may vary from those shown
Adroll
adroll